EIF5A and hepatocellular carcinoma: Additionally, eIF-5A and/or eIF-5A2 have been proposed as a transforming and predictive factor in the development of hepatocellular carcinoma, non-small cell lung cancer and in patients with ovarian carcinoma [32]–[34].